Drug Trial Radar · NCT04368559
Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation
Last checked: Nov 19, 2026Latest source record: Apr 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
602
Actual
Start
May 11, 2020
Primary completion
Jan 29, 2026
Study completion Jan 29, 2026
Sponsor
- Lead sponsor
- Mundipharma Research LimitedIndustry
- Sponsor type
- Industry
- First posted
- Apr 30, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this pivotal study is to determine if intravenous Rezafungin is efficacious and safe in the prevention of invasive fungal diseases when compared to the standard antimicrobial regimen.
Conditions
- Candidemia
- Mycoses
- Fungal Infection
- Fungemia
- Invasive Candidiasis
- Pneumocystis
- Mold Infection
- Invasive Fungal Disease
- Prophylaxis of Invasive Fungal Infections
- Aspergillus
Interventions
Rezafungin for InjectionDrug
Intravenous antifungal therapy
PosaconazoleDrug
Oral antifungal therapy
FluconazoleDrug
Oral antifungal therapy
Trimethoprim-sulfamethoxazole (TMP/SMX)Drug
Oral antibacterial therapy
Intravenous PlaceboDrug
Normal saline
Oral PlaceboDrug
Microcrystalline cellulose
Primary outcomes
What the sponsor says the trial is designed to measure.
- Noninferior Fungal-Free Survival (US FDA)Time frame: Day 90 (±7 days)
- Noninferior Fungal-Free Survival (US FDA)Time frame: Day 90 (±7 days)
- Superior Fungal-Free Survival (EMA)Time frame: Day 90 (±7 days)
- Superior Fungal-Free Survival (EMA)Time frame: Day 90 (±7 days)
Locations
53 sites in 9 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
UCLA Center for Health Sciences
Los Angeles, California
Stanford University School of Medicine
Stanford, California
Augusta University Medical Center
Augusta, Georgia
Rush University Medical Center
Chicago, Illinois
University of Chicago
Chicago, Illinois
University of Maryland Medical Center
Baltimore, Maryland
John Hopkins
Baltimore, Maryland
Massachusetts General Hospital
Boston, Massachusetts
University of Minnesota Physicians
Minneapolis, Minnesota
Mayo Clinic
Rochester, Minnesota
Mary Hitchcock Memorial Hospital Dartmouth-Hitchcock
Lebanon, New Hampshire
Hackensack University Medical Center
Hackensack, New Jersey
Stony Brook University Hospital
Stony Brook, New York
The University of Oklahoma College of Medicine
Oklahoma City, Oklahoma
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
VCU Medical Center Main Hospital
Richmond, Virginia
Fred Hutchinson Cancer Center
Seattle, Washington
University Hospitals Leuven, Campus Gasthuisberg - UZ Leuven
Leuven, Belgium
AZ Sint-Jan
Bruges, West Vlaanderen, Belgium
Hamilton Health Sciences' Juravinski Hospital
Hamilton, Canada
McGill University Health Center
Montreal, Canada
Jean Minjoz Hospital
Besançon, France
Henri Mondor Hospital
Créteil, France
Grenoble Alpes University Hospital Center
Grenoble, France
University Hospital of Limoges
Limoges, France
University Hospital of Nantes
Nantes, France
Hospital Saint Antoine Ap-Hp
Paris, France
University Hospital of Bordeaux
Pessac, France
Lyon-Sud Hospital Center
Pierre-Bénite, France
University Hospital of Cologne
Cologne, Germany
University Hospital Carl Gustav Carus Dresden
Dresden, Germany
Johannes Gutenberg University Medical Center
Mainz, Germany
University Hospital Münster
Münster, Germany
University Hospital Wurzburg UKW
Würzburg, Germany
San Martino Polyclinic Hospital
Genova, Italy
IEO Istituto Europeo di Oncologia
Milan, Italy
Agostino Gemelli University Policlinic
Rome, Italy
Humanitas Cancer Center
Rozzano, Italy
University Hospital Vall d'Hebron
Barcelona, Spain
Showing 40 of 53 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.